Overall and cause‐specific survival for patients undergoing lobectomy, near‐total, or total thyroidectomy for differentiated thyroid cancer
Brandon M. Barney(Mayo Clinic), Jonathan D. Tward(University of Utah), Dennis C. Shrieve(University of Utah), Ying J. Hitchcock(University of Utah), Pramod Kumar Sharma(SMS Medical College)
Cited by 224
Related Papers
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Nanoemulsion: an advanced mode of drug delivery system
|3 Biotech|2014|1.2k
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|631
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
|Journal of the National Comprehensive Cancer Network|2022|528
Head and Neck Cancers
|Journal of the National Comprehensive Cancer Network|2011|415